Looking Back at the Lance–Adams Syndrome: Uncommon and Unalike.

The article discusses the Lance-Adams Syndrome, a rare condition characterized by intention or action myoclonus that occurs as a result of hypoxic encephalopathy. The syndrome was first described in a seminal article in 1963 by James Lance and Raymond Adams. The article provides details about the archetypal cases of the syndrome, its clinical features, and the neuropathological findings associated with it. The treatment for Lance-Adams Syndrome has evolved over time, with current options including clonazepam and/or levetiracetam. The article also explores the prevalence of the syndrome and its differentiation from other forms of myoclonus. [Extracted from the article]